Brain Aneurysm Treatment Market Share and Forecast by 2027

The brain aneurysm treatment market was valued at US$ 2,184.15 million in 2019 and is expected to grow at a CAGR of 14.1% from 2020to 2027 to reach US$ 6,222.47 million by 2027.

Brain aneurysm is a development of bulge in brain vessels. This bulging puts pressure on the nerves or brain tissues. This bulge may rupture or burse and can cause brain hemorrhage, which can cause death of the patient. Certain factors such as genetic conditions, arteriovenous malformations, untreated high blood pressure, and smoking are responsible to cause brain aneurysm. The global brain aneurysm treatment market is driven by factors such as increasing prevalence of brain aneurysm and risk factors associated with it. Additionally, growing research and development activities in the field of brain and neurological disorders is also anticipated to drive the brain aneurysm market growth during the forecast period. However, high cost related with brain aneurysm treatment surgery is projected to obstruct the growth of the brain aneurysm treatment market during the forecast period. The developing healthcare infrastructure and extensively increasing screening tests in Asia Pacific for brain aneurysm are expected to create lucrative opportunity for the growth of the market.

Published Report - Brain Aneurysm Treatment Market: Strategic Insights

Market Insights

Rise in Research and Development Activities

Several healthcare organizations and industry players are implementing constructive strategies to boost the research and development programs pertaining to the treatment of brain aneurysm. For instance, in August 2019, Fujitsu Australia, Macquarie Medical Imaging, Macquarie University, and GE Healthcare announced a new research collaboration to find advanced techniques to improve the diagnosis of brain aneurysm. The association announced the focus on utilization and adoption of artificial intelligence to identify and analyze brain aneurysms.

Other companies in this space are also focusing on collaborative efforts to introduce new technologies and medical devices for the treatment of brain aneurysm. For instance, in December 2018, Medtronic received FDA approval for its Pipeline Flex, a permanent mesh cylinder (stent) for the treatment of brain aneurysm. Additionally, in January 2020, MicroVention, Inc. got FDA approval for its FRED (Flow Re-Direction Endoluminal Device) device for the treatment of brain aneurysms. An increasing number of such research and development activities are accelerating the growth of the market.

Type Insights

Based on Type, the Brain Aneurysm Treatment market is segmented into medication and surgery. In 2019 medication held the largest share of the market. However, surgery segment is expected to register the highest CAGR in the market during the forecast period.

Condition Insights

Based on condition, the brain aneurysm treatment market is segmented into unruptured aneurysm and ruptured aneurysm. The unruptured aneurysm held the largest share of disease segment in the global market. However, ruptured aneurysm is expected to grow at the faster rate during the forecast period. Increasing prevalence of ruptured aneurysm is projected to drive the ruptured aneurysm segment growth during the forecast period.

End User Insights

Based on end user, the brain aneurysm treatment market is segmented into hospitals and clinics. The hospitals held the largest share of end user segment in the global market. However, clinics segment is expected to grow at the fastest rate during the forecast period.

Product launches and FDA approvals strategy is commonly adopted by companies to expand their footprint worldwide and meet the growing demand. This strategy is most commonly adopted by the market players in order to expand its product portfolio.

The market players operating in the brain aneurysm treatment market adopt the strategy of collaborations to enlarge customer base across the world, which also permits the players to maintain their brand name globally.

Brain Aneurysm Treatment

Published Report - Brain Aneurysm Treatment Market Players Density: Understanding Its Impact on Business Dynamics

The Published Report - Brain Aneurysm Treatment Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.

Global Brain Aneurysm Treatment Market – By Type

• Medication
• Surgery

Global Brain Aneurysm Treatment Market – By Condition

• Unruptured Aneurysm
• Ruptured Aneurysm

Global Brain Aneurysm Treatment Market – By End User

• Hospitals
• Clinics

Brain Aneurysm Treatment Market– By Geography

• North America
  • US
  • Canada
  • Mexico

• Europe
  • France
  • Germany
  • Italy
  • UK
  • Spain
  • Rest of Europe

• Asia Pacific
  • China
  • India
  • South Korea
  • Japan
  • Australia
  • Rest of Asia Pacific

• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa

• South America
  • Brazil
  • Argentina
  • Rest of South America

Company Profiles

• Stryker Corporation
• MicroPort Scientific Corporation
• Terumo Corporation
• Mizuho Medical Co,Ltd
• Penumbra, Inc
• Medtronic
• Johnson & Johnson Services, Inc
• KANEKA CORPORATION
• adeor medical AG
• Evasc Medical Systems Corp